83 FR 210 pg. 54613 - Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research
Type: NOTICEVolume: 83Number: 210Page: 54613
Page: 54613Docket number: [Docket No. DEA-392]
FR document: [FR Doc. 2018-23695 Filed 10-29-18; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 31, 2018.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been delegated to the Assistant Administrator of the DEA Diversion Control Division ("Assistant Administrator") pursuant to section 7 of 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on June 14, 2018, Sigma Aldrich Research, 1-3 Strathmore Road, Natick, Massachusetts 01760-2447 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
| Controlled substance | Drug code | Schedule |
|---|---|---|
| Cathinone | 1235 | I |
| Mephedrone (4-Methyl-N-methylcathinone) | 1248 | I |
| Lysergic acid diethylamide | 7315 | I |
| 3,4-Methylenedioxymethamphetamine | 7405 | I |
| Dimethyltryptamine | 7435 | I |
| 5-Methoxy-N,N-diisopropyltryptamine | 7439 | I |
| MDPV (3,4-Methylenedioxypyrovalerone) | 7535 | I |
| Heroin | 9200 | I |
| Normorphine | 9313 | I |
| Norlevorphanol | 9634 | I |
| Amphetamine | 1100 | II |
| Nabilone | 7379 | II |
| Cocaine | 9041 | II |
| Codeine | 9050 | II |
| Ecgonine | 9180 | II |
| Levorphanol | 9220 | II |
| Meperidine | 9230 | II |
| Methadone | 9250 | II |
| Morphine | 9300 | II |
| Thebaine | 9333 | II |
| Levo-alphacetylmethadol | 9648 | II |
| Remifentanil | 9739 | II |
| Sufentanil | 9740 | II |
| Carfentanil | 9743 | II |
| Fentanyl | 9801 | II |
The company plans to manufacture reference standards.
Dated: October 11, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-23695 Filed 10-29-18; 8:45 am]
BILLING CODE 4410-09-P